NEW YORK (GenomeWeb) – British informatics firm Genomics plc today announced a collaboration with the University of Oxford and Oxford University Hospitals NHS Foundation Trust to analyze genomic sequences in rare diseases and cancer.

Under the terms of the agreement, the partners will work on a pilot study to establish genome sequencing as a clinical tool in rare diseases, cancers, and other disorders. Genomics will use its software to analyze up to 500 genome sequences, linking genotypes and phenotypes.

Financial terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.